ASML Holding NV
Change company Symbol lookup
Select an option...
ASML ASML Holding NV
FUN Cedar Fair LP
NWFFX American Funds New World Fund® Class F-1
CARS Cars.com Inc
AHT Ashford Hospitality Trust Inc
AHII Fyolo Technology Corp
AHH-A Armada Hoffler Properties Inc
AHH Armada Hoffler Properties Inc
AHFD Active Health Foods Inc
AGSO AgriSolar Solutions Inc
Go

Information Technology : Semiconductors & Semiconductor Equipment | Large Cap Growth
Based in Netherlands
Company profile

ASML Holding N.V. is a holding company. The Company is a manufacturer of chip-making equipment. The Company is engaged in the development, production, marketing, selling and servicing of semiconductor equipment systems, consisting of lithography systems. The Company's products include systems, and installed base products and services. The Company's principal operations are in the Netherlands, the United States and Asia. The Company offers TWINSCAN systems, equipped with lithography system with a mercury lamp as light source (i-line), Krypton Fluoride (KrF) and Argon Fluoride (ArF) light sources for 300 millimeter processing wafers for manufacturing environments for which imaging at a small resolution is required. TWINSCAN systems also include immersion lithography systems (TWINSCAN immersion systems). The Company also offers NXE systems, which are equipped with extreme ultraviolet (EUV) light source technology. The Company offers YieldStar, a wafer metrology system.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
$366.34
Day's Change
-0.40 (-0.11%)
Bid
--
Ask
--
B/A Size
--
Day's High
370.91
Day's Low
359.93
Volume
(Average)
Volume:
912,176

10-day average volume:
933,051
912,176

UnitedHealth Group Continues Efforts to Combat COVID-19, Reports Second Quarter Performance

5:55 am ET July 15, 2020 (BusinessWire) Print

During the second quarter of 2020, UnitedHealth Group (NYSE: UNH) expanded its COVID-19 response efforts, proactively supporting patients, customers, care providers and communities, including investing in outreach programs and clinical innovations to address the urgent needs of underserved communities disproportionately impacted by the disease.

"Our 325,000 dedicated team members, including the 120,000 clinicians serving on the front lines of care, have tirelessly responded to COVID-19 with agility, innovation and compassion," said David S. Wichmann, chief executive officer of UnitedHealth Group. "We moved swiftly to assist the people we serve and their care providers, including the provision of $3.5 billion in proactive voluntary customer assistance and accelerated care provider funding. We remain committed to taking further actions to address any future imbalances as a result of the pandemic."

Second quarter 2020 net earnings and adjusted net earnings per share of $6.91 and $7.12 were substantially higher than anticipated due primarily to the unprecedented, temporary deferral of care in the Company's risk-based businesses. The Company expects these results will be offset in the quarters ahead by the assistance measures already taken, the resumption of deferred care and future COVID-19 cost and economic impacts. As the pandemic advanced, access to and demand for care was most constrained from mid-March through April, began to recover in May and approached more typical levels by the end of the second quarter. The Company is maintaining its full year earnings per share outlook for 2020 of net earnings of $15.45 to $15.75 per share and adjusted net earnings of $16.25 to $16.55 per share.

Investments by the Company to support those affected by COVID-19 include extensive local market relief efforts, innovative health workforce safety initiatives, treatment and testing innovations and support for seniors and individuals experiencing homelessness and food insecurity. Building on years of investments in support of advancing health equity, the Company invested another $100 million in affordable housing to address homelessness and led numerous additional efforts to increase the availability of testing and treatment for COVID-19, including establishing more than 500 testing centers in underserved communities, deploying free COVID-19 mobile and local testing sites, health and safety kits, and education and outreach resources to underserved communities. The Company is also leading innovative clinical research to study the elevated risks and treatment options for COVID-19 associated with health conditions that disproportionately impact minority populations. A summary of the Company's COVID-19 response to date is included as part of this release.

              
Quarterly Financial Performance Quarterly Financial Performance
                    Three Months Ended                                             Three Months Ended                                                        
                                                         -------------------- ---------------------------------------------------------------------------------------------------
                                                                                                            
                         June 30,             June 30,             June 30,             June 30,             March 31,            March 31,         
                                                                 2020                 2020                 2019                 2019                 2020                 2020
                                                         -------------------- -------------------- -------------------- -------------------- -------------------- -------------------
                                  
Revenues                        Revenues                     $62.1 billion        $62.1 billion        $60.6 billion        $60.6 billion        $64.4 billion        $64.4 billion       
Earnings from Operations        Earnings from Operations     $9.2 billion         $9.2 billion         $4.7 billion         $4.7 billion         $5.0 billion         $5.0 billion        
Net Margin                      Net Margin                       10.7%                10.7%                5.4%                 5.4%                 5.2%                 5.2%            

UnitedHealth Group's second quarter 2020 revenues increased $1.5 billion to $62.1 billion, reflecting growth at Optum and the UnitedHealthcare public-sector and senior businesses, partially offset by economic-related impacts at UnitedHealthcare commercial and global. Second quarter earnings from operations increased $4.5 billion to $9.2 billion, impacted primarily by the previously described deferred care in the risk-based businesses, with this care expected to be delivered in future periods. Cash flows from operations were $10.0 billion or 1.5 times net income in the second quarter and $12.9 billion or 1.3 times net income year to date. The second quarter medical care ratio was impacted by the temporary deferral of care due to the pandemic, declining to 70.2% from 83.1% last year. The Company expects the medical care ratio to rise in coming quarters as needed care is accessed. Favorable reserve development was $1.4 billion in the second quarter, nearly all related to the current year, and primarily due to higher than expected care deferrals in late March, further lowering the second quarter medical care ratio. Days claims payable were 50.4 days compared to 48.6 in the second quarter 2019 and 50.5 in the first quarter 2020. The operating cost ratio of 16.1% in the second quarter of 2020 increased from 13.9% in the same period last year, primarily due to the health insurance tax, COVID-19 response efforts and business mix. The Company returned $1.2 billion to shareholders in the second quarter via dividends, while the debt to total capital ratio was 40.9% at quarter end. Return on equity of 33.7% for the first half of 2020 reflects continued strong core operating performance and the temporary impact of care deferrals experienced during the second quarter 2020.

UnitedHealthcare provides global health care benefits, serving individuals and employers, and Medicare and Medicaid beneficiaries. UnitedHealthcare is dedicated to improving the value health care consumers receive by reducing the total cost of care, enhancing the quality of care received, improving health and wellness and simplifying the health care experience.

              
Quarterly Financial Performance Quarterly Financial Performance
                    Three Months Ended                                             Three Months Ended                                                        
                                                         -------------------- ---------------------------------------------------------------------------------------------------
                                                                                                            
                         June 30,             June 30,               June 30,               March 31,         
                                                                 2020                 2020                                      2019                                      2020
                                                         -------------------- --------------------                      --------------------                      -------------------
                                  
Revenues                        Revenues                     $49.1 billion        $49.1 billion          $48.6 billion          $51.1 billion       
Earnings from Operations        Earnings from Operations     $7.0 billion         $7.0 billion           $2.6 billion           $2.9 billion        
Operating Margin                Operating Margin                 14.3%                14.3%                  5.4%                   5.7%            

UnitedHealthcare second quarter revenues of $49.1 billion compare to $48.6 billion in the year ago quarter, as growth in serving public-sector and senior programs was partially offset by commercial enrollment declines. UnitedHealthcare public-sector and senior program revenue, including Medicare and Medicaid, grew by 7% year-over-year in the quarter and by nearly 600,000 additional people served year to date, while commercial revenue was impacted by economic-driven member attrition. Operating earnings of $7.0 billion compare to last year's $2.6 billion, with comparatively higher growth and operating margins compared to prior periods driven by the temporary impact of deferred care, net of COVID-19 treatment costs and the initial impact of a decelerating economy. The Company expects future quarters will reflect the restoration of care patterns and the impact of its $1.5 billion in customer assistance actions against the backdrop of an uncertain economic recovery. Further UnitedHealthcare growth highlights include: Medicaid business wins in Kentucky and Indiana; continued growth in serving people in dual special needs plans; gains in serving individuals' health benefits needs in the commercial marketplace; and launch of GetCovered, a national, multicarrier service offering consumers information, guidance, enrollment, support and affordable coverage across 200 independent individual health and local Medicaid plans supported by the Company's HealthMarkets benefits representatives.

Optum is a health services business serving the global health care marketplace, including payers, care providers, employers, governments, life sciences companies and consumers. Using market-leading information, data analytics, technology and clinical insights, Optum helps improve overall health system performance: optimizing care quality, reducing health care costs and improving the consumer experience.

              
Quarterly Financial Performance Quarterly Financial Performance
                    Three Months Ended                                             Three Months Ended                                                        
                                                         -------------------- ---------------------------------------------------------------------------------------------------
                                                                                                            
                         June 30,             June 30,               June 30,               March 31,         
                                                                 2020                 2020                                      2019                                      2020
                                                         -------------------- --------------------                      --------------------                      -------------------
                              
Revenues                        Revenues                     $32.7 billion        $32.7 billion          $28.0 billion          $32.8 billion       
Earnings from Operations        Earnings from Operations     $2.2 billion         $2.2 billion           $2.1 billion           $2.1 billion        
Operating Margin                Operating Margin                 6.8%                 6.8%                   7.5%                   6.4%            

Optum second quarter revenues and operating earnings of $32.7 billion and $2.2 billion respectively advanced from $28.0 billion and $2.1 billion a year ago, led by earnings growth at OptumHealth. OptumHealth served approximately 97 million people in the second quarter, compared to 95 million a year ago, while revenue per consumer served grew 25% year-over-year driven by continued growth in value-based care arrangements. The OptumHealth care delivery practices were impacted early in the quarter due to the pandemic. By June, care patterns had returned to near normal levels. Over the course of the quarter, the Company accelerated the growth of its employed and affiliated physicians at OptumCare. The OptumInsight revenue backlog rose to $19.4 billion at quarter end, an increase of nearly $1 billion year-over-year, driven by growth in technology and managed services across the business. Activity levels within OptumInsight's volume-based services were negatively affected by care deferrals. At OptumRx, diversified growth in areas such as home infusion services, community-based behavioral health pharmacies, e-commerce and specialty pharmaceuticals partially offset the negative impact of reduced first fill prescription volumes, driven by COVID-19 related care deferral. As care delivery activity has been recovering over the course of the quarter, script volumes have begun to return to more normal levels. Further Optum growth highlights include: extending geographic presence and distinctive capabilities through strategic acquisitions in infusion services (Diplomat Pharmacy), post-acute care (NaviHealth) and digital behavioral health (AbleTo); launching the Boulder Community Health partnership; providing testing services in California, Indiana and Florida; and launching digital at home and rare disease pharmacy programs.

COVID-19 Response to Date

Coronavirus (COVID-19) is profoundly impacting the health of people around the world, as well as our global economies. The safety and health of the people we serve, our team members, their families, our stakeholders, broader communities and the reliability of our health care systems consume our resources and our focus.

Care of Our Team Members                                                                                                                                                                            Serving Society
Within days, 90% of our nonclinical workforce was temporarily transitioned to a work at home status while maintaining all service levels.                                                                              Selected by HHS to assist in processing and distributing $100 billion CARES Act funding to care delivery providers.
We increased compensation for our front-line clinical workforce in high incidence communities.                                                                                                                         Joined forces with Microsoft to launch ProtectWell,(TM) an innovative return-to-workplace protocol that enables employers to bring employees back to the workplace.
Serving Customers, Members and Patients                                                                                                                                                                                Developed and tested a new FDA approved self-administered COVID-19 swab protocol and led a study resulting in FDA approval for the use of alternative swab materials, providing more options for sample collection.
Provided $1.5 billion in direct customer and consumer support through premium credits, cost-sharing waivers and other efforts. Expect another $1 billion in rebates to be paid in future periods.                      Published a study with Yale School of Medicine that showed the use of ACE inhibitors was associated with an almost 40% lower risk of COVID-19 hospitalization for Medicare Advantage patients.
Accelerated nearly $2 billion of payments to care providers to provide needed liquidity for the health system.                                                                                                         Conducting a first of its kind 10,000-person virtual clinical trial with Yale Medical School to examine the potential role of ACE inhibitors in preventing severe consequences of COVID-19.
Waived all cost sharing for COVID-19 diagnosis and treatment.                                                                                                                                                          Partnering with the Morehouse School of Medicine to study the effect of sickle cell trait, which is prevalent in 8-10% of Black Americans, on COVID-19.
Provided unlimited free telehealth services.                                                                                                                                                                           Partnered with Boston Scientific, Medtronic and the University of Minnesota to develop and deploy 3,000 "light ventilators" to address critical shortages.
Removed all COVID-19 prior authorizations.                                                                                                                                                                             Donated $5 million to accelerate and expand Mayo Clinic's study of convalescent plasma treatments.
Provided early refills, extended authorizations and increased home delivery options of medication to ensure no shortages.                                                                                              Opened free access to our mental health mobile app and 24/7 emotional support phone lines.
Extended grace periods for employers and individuals to pay premiums.                                                                                                                                                  Provided more than $100 million in support to date to those affected by COVID-19, including community relief efforts, health workforce safety, seniors, and individuals experiencing homelessness and food insecurity.
Deployed triage tools, including a symptom checker with next best action recommendations.                                                                                                                              Scaled a mobile and local testing program to address health disparities and meet the unique needs of disadvantaged communities in Los Angeles, Philadelphia and Orleans Parish.
Shifted more than 14,000 OptumCare physicians to telehealth for patient visits that would have otherwise been canceled.                                                                                                Announced that we will not request, nor do we intend to retain, any government assistance.
Deployed 700 Advance Practice Clinicians to expand telehealth services.                                                                                                                                                 
Introduced a special enrollment period to allow commercial customers to add employees who previously declined health benefit coverage.
Hired by California, Indiana and Jacksonville, Florida to expand COVID-19 testing, with an emphasis on serving underserved communities.
Increased the number of behavioral health professionals using our proprietary online behavioral health platform by 45% to more than 10,000.
Developed a cash discount option for members who have lost pharmacy benefit coverage.
Facilitated infusion services to the home that were traditionally administered in hospital or clinic settings.

About UnitedHealth Group

UnitedHealth Group (NYSE: UNH) is a diversified health care company dedicated to helping people live healthier lives and helping make the health system work better for everyone. UnitedHealth Group offers a broad spectrum of products and services through two distinct platforms: UnitedHealthcare, which provides health care coverage and benefits services; and Optum, which provides information and technology-enabled health services. For more information, visit UnitedHealth Group at www.unitedhealthgroup.com or follow @UnitedHealthGrp on Twitter.

Earnings Conference Call

As previously announced, UnitedHealth Group will discuss the company's results, strategy and future outlook on a conference call with investors at 8:45 a.m. Eastern Time today. UnitedHealth Group will host a live webcast of this conference call from the Investor Relations page of the company's website (www.unitedhealthgroup.com). Following the call, a webcast replay will be available on the same site through July 29, 2020. The conference call replay can also be accessed by dialing 1-800-688-7339. This earnings release and the Form 8-K dated July 15, 2020, can also be accessed from the Investor Relations page of the company's website.

Non-GAAP Financial Information

This news release presents non-GAAP financial information provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America ("GAAP"). A reconciliation of the non-GAAP financial information to the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end of this release.

Forward-Looking Statements

The statements, estimates, projections, guidance or outlook contained in this document include "forward-looking" statements which are intended to take advantage of the "safe harbor" provisions of the federal securities law. The words "believe," "expect," "intend," "estimate," "anticipate," "forecast," "outlook," "plan," "project," "should" and similar expressions identify forward-looking statements. These statements may contain information about financial prospects, economic conditions and trends and involve risks and uncertainties. Actual results could differ materially from those that management expects, depending on the outcome of certain factors including: risks associated with public health crises, large-scale medical emergencies and pandemics, such as the COVID-19 pandemic; our ability to effectively estimate, price for and manage medical costs; new or changes in existing health care laws or regulations, or their enforcement or application; the DOJ's legal action relating to the risk adjustment submission matter; our ability to maintain and achieve improvement in quality scores impacting revenue; reductions in revenue or delays to cash flows received under government programs; changes in Medicare, the CMS star ratings program or the application of risk adjustment data validation audits; failure to maintain effective and efficient information systems or if our technology products do not operate as intended; cyberattacks, other privacy/data security incidents, or our failure to comply with related regulations; risks and uncertainties associated with the pharmacy benefits management industry; competitive pressures; changes in or challenges to our public sector contract awards; our ability to contract on competitive terms with physicians, hospitals and other service providers; failure to achieve targeted operating cost productivity improvements; increases in costs and other liabilities associated with litigation, government investigations, audits or reviews; failure to manage successfully our strategic alliances or complete or receive anticipated benefits of strategic transactions; fluctuations in foreign currency exchange rates; downgrades in our credit ratings; our investment portfolio performance; impairment of our goodwill and intangible assets; and our ability to obtain sufficient funds from our regulated subsidiaries or from external financings to fund our obligations, maintain our debt to total capital ratio at targeted levels, maintain our quarterly dividend payment cycle, or continue repurchasing shares of our common stock. This above list is not exhaustive. We discuss these matters, and certain risks that may affect our business operations, financial condition and results of operations more fully in our filings with the SEC, including our reports on Forms 10-K, 10-Q and 8-K. By their nature, forward-looking statements are not guarantees of future performance or results and are subject to risks, uncertainties and assumptions that are difficult to predict or quantify. Actual results may vary materially from expectations expressed or implied in this document or any of our prior communications. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. We do not undertake to update or revise any forward-looking statements, except as required by law.

                   UNITEDHEALTH GROUP
Earnings Release Schedules and Supplementary Information
               Quarter Ended June 30, 2020
- Condensed Consolidated Statements of Operations
- Condensed Consolidated Balance Sheets
- Condensed Consolidated Statements of Cash Flows
- Supplemental Financial Information - Businesses
- Supplemental Financial Information - Business Metrics
                                                                                                                                                                               UNITEDHEALTH GROUP
                                                                                                                                                                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                                                                                                                                                      (in millions, except per share data)
                                                                                                                                                                                   (unaudited)
                                                                                                                                                                        
                                  Three Months Ended                                    Three Months Ended                                                    Three Months Ended                                                                                                         Six Months Ended
                                       June 30,                                              June 30,                                                              June 30,                                                                                                                                     June 30,
-------------------------------------------------------------------------------------- -------------------- ----------------------------------------------------------------------------------------------------------------                            ------------------------------------------------------------------------------------------------------------------
                                         2020                                                  2020                               2020                                               2019                                                2020                                                2019
-------------------------------------------------------------------------------------- -------------------- ----------------------------------------------                        ----------------------------------------------                        -----------------------------------------------                        -----------------------------------------------
Revenues
Premiums                                                                                                  $                    $ 49,394                      $                    $ 47,164                      $                    $ 100,034                      $                    $  94,677  
Products                                                                                    8,247        8,353        16,678        16,425  
Services                                                                                    4,156        4,496         9,141         8,814  
Investment and other income                                                                   341          582           706           987  
                                                                                       -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------- -------------------- -------------------- -------------------- ------- --------------------
     Total revenues                                                                        62,138       60,595       126,559       120,903  
                                                                                       -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------- -------------------- -------------------- -------------------- ------- --------------------
Operating costs
Medical costs                                                                              34,678       39,184        75,678        78,123  
Operating costs                                                                            10,001        8,415        20,016        16,932  
Cost of products sold                                                                       7,501        7,598        15,188        14,979  
Depreciation and amortization                                                                 717          654         1,440         1,293  
                                                                                       -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------- -------------------- -------------------- -------------------- ------- --------------------
     Total operating costs                                                                 52,897       55,851       112,322       111,327  
                                                                                       -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------- -------------------- -------------------- -------------------- ------- --------------------
Earnings from operations                                                                    9,241        4,744        14,237         9,576  
Interest expense                                                                             (430                    )       (418                    )        (867                    )        (818                    )
                                                                                       -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------- -------------------- -------------------- -------------------- ------- --------------------
Earnings before income taxes                                                                8,811        4,326        13,370         8,758  
Provision for income taxes                                                                 (2,115                    )       (941                    )      (3,209                    )      (1,816                    )
                                                                                       -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------- -------------------- -------------------- -------------------- ------- --------------------
Net earnings                                                                                6,696        3,385        10,161         6,942  
Earnings attributable to noncontrolling interests                                             (59                    )        (92                    )        (142                    )        (182                    )
                                                                                       -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------- -------------------- -------------------- -------------------- ------- --------------------
Net earnings attributable to UnitedHealth Group common shareholders                                       $                    $  6,637                      $                    $  3,293                      $                    $  10,019                      $                    $   6,760  
                                                                                       ==================== ==================== ====== ==================== ==================== ==================== ====== ==================== ==================== ==================== ======= ==================== ==================== ==================== ======= ====================
Diluted earnings per share attributable to UnitedHealth Group common shareholders                         $                    $   6.91                      $                    $   3.42                      $                    $   10.43                      $                    $    6.97  
                                                                                       ==================== ==================== ====== ==================== ==================== ==================== ====== ==================== ==================== ==================== ======= ==================== ==================== ==================== ======= ====================
Adjusted earnings per share attributable to UnitedHealth Group common shareholders (a)                    $                    $   7.12                      $                    $   3.60                      $                    $   10.84                      $                    $    7.33  
                                                                                       ==================== ==================== ====== ==================== ==================== ==================== ====== ==================== ==================== ==================== ======= ==================== ==================== ==================== ======= ====================
Diluted weighted-average common shares outstanding                                            960          964           961           970  
                                                                                       ==================== ==================== ====== ==================== ==================== ==================== ====== ==================== ==================== ==================== ======= ==================== ==================== ==================== ======= ====================
                                                                                                                                                                        
                                                                           UNITEDHEALTH GROUP
                                                                  CONDENSED CONSOLIDATED BALANCE SHEETS
                                                                              (in millions)
                                                                               (unaudited)
                                                              
                           June 30,                                  June 30,                   June 30,                        December 31,
                             2020                                      2020                       2020                              2019
-------------------------------------------------------------- -------------------- ------------------------------                       ------------------------------
Assets
Cash and short-term investments                                                   $                    $     25,593                    $                    $     14,245
Accounts receivable, net                                               12,546         11,822
Other current assets                                                   20,779         16,567
                                                               -------------------- -------------------- ---------- -------------------- -------------------- ----------
      Total current assets                                             58,918         42,634
Long-term investments                                                  36,778         37,209
Other long-term assets                                                 96,787         94,046
                                                               -------------------- -------------------- ---------- -------------------- -------------------- ----------
   Total assets                                                                   $                    $    192,483                    $                    $    173,889
                                                               ==================== ==================== ========== ==================== ==================== ==========
                                                              
Liabilities, redeemable noncontrolling interests and equity
Medical costs payable                                                             $                    $     19,200                    $                    $     21,690
Short-term borrowings and current maturities of long-term debt          6,156          3,870
Other current liabilities                                              44,527         36,222
                                                               -------------------- -------------------- ---------- -------------------- -------------------- ----------
      Total current liabilities                                        69,883         61,782
Long-term debt, less current maturities                                39,901         36,808
Other long-term liabilities                                            14,342         13,137
Redeemable noncontrolling interests                                     1,842          1,726
Equity                                                                 66,515         60,436
                                                               -------------------- -------------------- ---------- -------------------- -------------------- ----------
                                                                                                            UNITEDHEALTH GROUP
                                                                                              CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                                                                                               (in millions)
                                                                                                                (unaudited)
                                                                                                               
                                       Six Months Ended                                          Six Months Ended                                                      Six Months Ended
                                           June 30,                                                  June 30,                                                              June 30,
---------------------------------------------------------------------------------------------- -------------------- ----------------------------------------------------------------------------------------------------------------
                                             2020                                                      2020                               2020                                               2019
---------------------------------------------------------------------------------------------- -------------------- ----------------------------------------------                        ----------------------------------------------
Operating Activities
Net earnings                                                                                                      $                    $ 10,161                      $                    $  6,942  
Noncash items:
     Depreciation and amortization                                                                  1,440        1,293  
     Deferred income taxes and other                                                                  238           68  
     Share-based compensation                                                                         388          398  
Net changes in operating assets and liabilities                                                       719          407  
                                                                                               -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------ --------------------
     Cash flows from operating activities                                                          12,946        9,108  
                                                                                               -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------ --------------------
Investing Activities
Sales and maturities of investments, net of purchases (purchases, net of sales and maturities)        573       (1,654                    )
Purchases of property, equipment and capitalized software                                            (920                    )       (977                    )
Cash paid for acquisitions, net                                                                    (3,952                    )     (4,751                    )
Other, net                                                                                           (186 )                           504  
                                                                                               -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------ --------------------
     Cash flows used for investing activities                                                      (4,485                    )     (6,878                    )
                                                                                               -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------ --------------------
Financing Activities
Common share repurchases                                                                           (1,691 )                        (4,501 )
Dividends paid                                                                                     (2,212 )                        (1,884 )
Net change in short-term borrowings and long-term debt                                              5,215        5,674  
Other, net                                                                                          1,712        1,354  
                                                                                               -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------ --------------------
     Cash flows from financing activities                                                           3,024          643  
                                                                                               -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------ --------------------
Effect of exchange rate changes on cash and cash equivalents                                         (143                    )          6  
                                                                                               -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------ --------------------
Increase in cash and cash equivalents                                                              11,342        2,879  
Cash and cash equivalents, beginning of period                                                     10,985       10,866  
                                                                                               -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------ --------------------
                                                                                                                                                             UNITEDHEALTH GROUP
                                                                                                                                               SUPPLEMENTAL FINANCIAL INFORMATION - BUSINESSES
                                                                                                                                                      (in millions, except percentages)
                                                                                                                                                                 (unaudited)
                                                                                                                                    
               Three Months Ended                 Three Months Ended                                                     Three Months Ended                                                                                                          Six Months Ended
                    June 30,                           June 30,                                                               June 30,                                                                                                                                      June 30,
------------------------------------------------ -------------------- ------------------------------------------------------------------------------------------------------------------                            ------------------------------------------------------------------------------------------------------------------
                      2020                               2020                                2020                                                2019                                                2020                                                2019
------------------------------------------------ -------------------- -----------------------------------------------                        -----------------------------------------------                        -----------------------------------------------                        -----------------------------------------------
Revenues
UnitedHealthcare                                                    $                    $  49,107                      $                    $  48,594                      $                    $ 100,175                      $                    $  97,490  
Optum                                                 32,695        28,029        65,534        54,389  
Eliminations                                         (19,664                    )     (16,028                    )     (39,150                    )     (30,976                    )
                                                 -------------------- -------------------- ------- -------------------- -------------------- -------------------- ------- -------------------- -------------------- -------------------- ------- -------------------- -------------------- -------------------- ------- --------------------
     Total consolidated revenues                                    $                    $  62,138                      $                    $  60,595                      $                    $ 126,559                      $                    $ 120,903  
                                                 ==================== ==================== ======= ==================== ==================== ==================== ======= ==================== ==================== ==================== ======= ==================== ==================== ==================== ======= ====================
Earnings from Operations
UnitedHealthcare                                                    $                    $   7,007                      $                    $   2,642                      $                    $   9,895                      $                    $   5,596  
Optum (a)                                              2,234         2,102         4,342         3,980  
                                                 -------------------- -------------------- ------- -------------------- -------------------- -------------------- ------- -------------------- -------------------- -------------------- ------- -------------------- -------------------- -------------------- ------- --------------------
     Total consolidated earnings from operations                    $                    $   9,241                      $                    $   4,744                      $                    $  14,237                      $                    $   9,576  
                                                 ==================== ==================== ======= ==================== ==================== ==================== ======= ==================== ==================== ==================== ======= ==================== ==================== ==================== ======= ====================
Operating Margin
UnitedHealthcare                                        14.3                    %         5.4                    %         9.9                    %         5.7                    %
Optum                                                    6.8                    %         7.5                    %         6.6                    %         7.3                    %
     Consolidated operating margin                      14.9                    %         7.8                    %        11.2                    %         7.9                    %
                                                                                                                                    
Revenues
UnitedHealthcare Employer & Individual                              $                    $  12,963                      $                    $  14,032                      $                    $  27,243                      $                    $  28,116  
UnitedHealthcare Medicare & Retirement                22,855        20,855        46,007        41,951  
UnitedHealthcare Community & State                    11,523        11,186        22,976        22,368  
UnitedHealthcare Global                                1,766         2,521         3,949         5,055  
                                                                                                                                    
OptumHealth                                                         $                    $   9,139                      $                    $   7,148                      $                    $  18,331                      $                    $  13,861  
OptumInsight                                           2,632         2,339         5,126         4,528  
OptumRx                                               21,371        18,923        42,928        36,740  
 (a)Earnings from operations for Optum for the three and six months ended June 30, 2020 included $841 and $1,553 for OptumHealth; $561 and $1,097 for OptumInsight; and $832 and $1,692 for OptumRx, respectively. Earnings from operations for Optum for the three and six months ended June 30, 2019 included $688 and $1,314 for OptumHealth; $525 and $957 for OptumInsight; and $889 and $1,709 for OptumRx, respectively.
                                                                                                   UNITEDHEALTH GROUP
                                                                                  SUPPLEMENTAL FINANCIAL INFORMATION - BUSINESS METRICS
                                             
                                                                                            UNITEDHEALTHCARE CUSTOMER PROFILE
                                                                                                     (in thousands)
                                             
People Served                                        June 30, 2020        June 30, 2020       March 31, 2020       March 31, 2020      December 31, 2019    December 31, 2019      June 30, 2019        June 30, 2019
------------------------------------------------ -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- --------------------
Commercial:
     Risk-based                                                 8,065                8,065                8,215                8,215                8,575                8,575                8,325                8,325
     Fee-based                                                 18,705               18,705               18,825               18,825               19,185               19,185               19,090               19,090
                                                 -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- --------------------
     Total Commercial                                          26,770               26,770               27,040               27,040               27,760               27,760               27,415               27,415
                                                 -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- --------------------
Medicare Advantage                                              5,605                5,605                5,575                5,575                5,270                5,270                5,190                5,190
Medicaid                                                        6,210                6,210                5,880                5,880                5,900                5,900                6,360                6,360
Medicare Supplement (Standardized)                              4,450                4,450                4,440                4,440                4,500                4,500                4,495                4,495
                                                 -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- --------------------
     Total Public and Senior                                   16,265               16,265               15,895               15,895               15,670               15,670               16,045               16,045
                                                 -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- --------------------
     Total UnitedHealthcare - Domestic Medical                 43,035               43,035               42,935               42,935               43,430               43,430               43,460               43,460
Global                                                          5,365                5,365                5,605                5,605                5,720                5,720                6,070                6,070
                                                 -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- --------------------
     Total UnitedHealthcare - Medical                          48,400               48,400               48,540               48,540               49,150               49,150               49,530               49,530
                                                 ==================== ==================== ==================== ==================== ==================== ==================== ==================== ====================
                                             
Supplemental Data
     Medicare Part D stand-alone                                4,120                4,120                4,150                4,150                4,405                4,405                4,430                4,430
                                                 ==================== ==================== ==================== ==================== ==================== ==================== ==================== ====================
                                             
                                             
                                                                                                OPTUM PERFORMANCE METRICS
                                             
                  June 30, 2020                      June 30, 2020        June 30, 2020       March 31, 2020       March 31, 2020      December 31, 2019    December 31, 2019      June 30, 2019        June 30, 2019
------------------------------------------------ -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- --------------------
                                             
OptumHealth Consumers Served (in millions)                         97                   97                   96                   96                   96                   96                   95                   95
OptumInsight Contract Backlog (in billions)                     $19.4                $19.4                $19.2                $19.2                $19.3                $19.3                $18.5                $18.5
OptumRx Quarterly Adjusted Scripts (in millions)                  316                  316                  339                  339                  333                  333                  343                  343
                                             
                                                                                                                                                                                                 UNITEDHEALTH GROUP
                                                                                                                                                                                    RECONCILIATION OF NON-GAAP FINANCIAL MEASURE
                                                                                                                                                                                        (in millions, except per share data)
                                                                                                                                                                                                     (unaudited)
                                                                                                                                                                                                  
                                                                                                                                                                                         ADJUSTED NET EARNINGS PER SHARE(a)
                                                                                                                                                                                                  
                                Three Months Ended                                 Three Months Ended                                                    Three Months Ended                                                                                                        Six Months Ended                                                            Projected
                                     June 30,                                           June 30,                                                              June 30,                                                                                                                                    June 30,                                                                                  Year Ended
                                                                                                                                                                                                                                                                                                                                                                                                   December 31,
--------------------------------------------------------------------------------- -------------------- ----------------------------------------------------------------------------------------------------------------                            ----------------------------------------------------------------------------------------------------------------                            --------------------
                                       2020                                               2020                               2020                                               2019                                               2020                                               2019                                2020(b)
--------------------------------------------------------------------------------- -------------------- ----------------------------------------------                        ----------------------------------------------                        ----------------------------------------------                        ----------------------------------------------                        --------------------
GAAP net earnings attributable to UnitedHealth Group common shareholders                             $                    $  6,637                      $                    $  3,293                      $                    $ 10,019                      $                    $  6,760      $14,750 - $15,050    $14,750 - $15,050
Intangible amortization                                                                  267          240          532          467                  1,025                1,025
Tax effect of intangible amortization                                                    (65                    )        (60                    )       (130                    )       (116                    )                (250)                (250)
                                                                                  -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------ -------------------- -------------------- --------------------
     Adjusted net earnings attributable to UnitedHealth Group common shareholders                    $                    $  6,839                      $                    $  3,473                      $                    $ 10,421                      $                    $  7,111      $15,525 - $15,825    $15,525 - $15,825
                                                                                  ==================== ==================== ====== ==================== ==================== ==================== ====== ==================== ==================== ==================== ====== ==================== ==================== ==================== ====== ==================== ==================== ====================
                                                                                                                                                                                                  
GAAP diluted earnings per share                                                                      $                    $   6.91                      $                    $   3.42                      $                    $  10.43                      $                    $   6.97        $15.45 - $15.75      $15.45 - $15.75
Intangible amortization per share                                                       0.28         0.24         0.55         0.48                   1.05                 1.05
Tax effect per share of intangible amortization                                        (0.07                    )      (0.06                    )      (0.14                    )      (0.12                    )               (0.25)               (0.25)
                                                                                  -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------ -------------------- -------------------- -------------------- ------ -------------------- -------------------- --------------------
(a)                  Adjusted net earnings per share is a non-GAAP financial measure. Non-GAAP financial measures should be considered in addition to, but not as a substitute for, or superior to, financial measures prepared in accordance with GAAP.
   
  Adjusted net earnings per share excludes from the relevant GAAP metric, as applicable, intangible amortization and other items, if any, that do not relate to the Company's underlying business performance. Management believes that the use of adjusted net earnings per share provides investors and management useful information about the earnings impact of acquisition-related intangible asset amortization. As amortization fluctuates based on the size and timing of the Company's acquisition activity, management believes this exclusion provides a more useful comparison of the Company's underlying business performance and trends from period to period. While intangible assets contribute to the Company's revenue generation, the intangible amortization is not directly related. Therefore, the related revenues are included in adjusted earnings per share.
   

View source version on businesswire.com: https://www.businesswire.com/news/home/20200715005287/en/

SOURCE: UnitedHealth Group

Investors: 
Brett Manderfeld
Senior Vice President
952-936-7216


Media: 
Matt Stearns
Senior Vice President
202-276-0085
comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.